Theragenics Corporation(R) Announces Schedule for Second Quarter 2008 Conference...

Theragenics Corporation(R) Announces Schedule for Second Quarter 2008 Conference Call

BUFORD, Ga.--(Business Wire)--
Theragenics Corporation (NYSE:TGX), a medical device company
serving the surgical products and prostate cancer treatment markets,
will release its second quarter consolidated financial results before
the market opens on Thursday, July 31, 2008. Following the release,
the Company will host a conference call at 11:00 a.m. Eastern.

To participate in the call, dial 800-538-9844 or 706-634-7274 and
provide the conference ID 55962103. This call is also being web cast
and can be accessed via the Company's Website. Log on to
www.theragenics.com and select Investor Relations, company
presentations. A replay will be available on the Website for one
month. A phone replay will also be available until Midnight, August 7,
by dialing 800-642-1687 or 706-645-9291 and entering the conference ID
55962103.

Theragenics Corporation (NYSE:TGX) operates two business segments:
its surgical products business and its brachytherapy seed business.
Its surgical products business (www.cpmedical.com and
www.galtmedical.com) manufactures and distributes wound closure and
vascular access products. Wound closure products include sutures,
needles and other surgical products with applications in, among other
areas, urology, veterinary, cardiology, orthopedics, plastic surgery
and dental. Vascular access includes introducers and guidewires used
in the interventional radiology, interventional cardiology and
vascular surgery markets. The brachytherapy business manufactures and
markets its premier product, the palladium-103 TheraSeed(R) device
(www.theraseed.com) and I-Seed, an iodine-125 based device, which are
used primarily in the minimally invasive treatment of localized
prostate cancer. For additional information, call Theragenics'
Investor Relations Department at (800) 998-8479 or visit
www.theragenics.com.

Theragenics Corporation
Frank J. Tarallo, CFO & Treasurer
Lisa Rassel, Manager, Investor Relations
770-271-0233, 800-998-8479

Copyright Business Wire 2008